NHS risks losing specialty to private sector, says royal college
A royal college has sparked a row with independent sector bosses after warning ophthalmology risks becoming largely privatised unless NHS England radically changes the specialty’s “chaotic” commissioning arrangements. (Source: HSJ)
Source: HSJ - December 21, 2023 Category: UK Health Source Type: news
Champagne bottles should have SCREW caps to avoid risk of eye injuries, doctors say: Corks can fly out at 50mph and blind people
Experts from the University of Cambridge 's Department of Ophthalmology say the warning may seem overly cautious but cork eye injuries are a substantial threat to eye health. (Source: the Mail online | Health)
Source: the Mail online | Health - December 21, 2023 Category: Consumer Health News Source Type: news
Watch out for cork accidents this festive season
Cork eye injuries are an often overlooked and a substantial threat to optical health, that could even lead to permanent blindness. (Source: Daily Express - Health)
Source: Daily Express - Health - December 20, 2023 Category: Consumer Health News Source Type: news
FDA Approves Groundbreaking iDose ® TR for Glaucoma Treatment Following Successful Clinical Trials Conducted by Parkhurst NuVision and Glaukos
Parkhurst NuVision, a leading ophthalmic clinic and Glaukos have reached a significant milestone with the U.S. Food and Drug Administration (FDA) approval of its New Drug Application (NDA) for iDose® TR (travoprost intracameral implant) 75 mcg. This pioneering prostaglandin analog... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 19, 2023 Category: Pharmaceuticals Tags: TRI FDA Source Type: news
Metro nonprofit focused on eyesight appoints new CEO
The new executive is a longtime professor from UAB. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 19, 2023 Category: Biotechnology Authors: Stephanie Rebman Source Type: news
JB Pharma inks Rs 1,089 cr pacts with Novartis for select ophthalmology brands
The board of directors at its meeting held on December 19, 2023 approved the execution of a trade mark licence agreement with Novartis Innovative Therapies AG, which is perpetual in nature for the Indian market, for a portfolio of select ophthalmology brands which will be effective in January 2027, JB Pharma said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 19, 2023 Category: Pharmaceuticals Source Type: news
SightMD Connecticut Welcomes Kimberly Ann Lucey, M.D., P.C.
SightMD Connecticut, a leading multi-specialty ophthalmology platform, announced a strategic partnership with Kimberly Ann Lucey M.D. Through this strategic partnership Dr. Lucey's practice at 1699 King Street, Suite 102 in Enfield, CT, will expand SightMD Connecticut's presence.... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 18, 2023 Category: Pharmaceuticals Source Type: news
Electrifying Results: Restoring Partial Color Vision In Retinitis Pigmentosa Patients With Retinal Implants
Retinal implants have recently gained attention as a potential treatment for RP-induced color blindness. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 16, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
Eserine, in Crooked House and Curtain - Takao M.
Eserine, well-known as physostigmine, is classified as an alkaloid. It is a cholinesterase inhibitor and appears in Agatha Christie's novel entitled, Crooked House and Curtain: Poirot's Last Case. In clinical medicine, eserine was used as an ophthalmic tre... (Source: SafetyLit)
Source: SafetyLit - December 16, 2023 Category: International Medicine & Public Health Tags: Poisoning Source Type: news
Eserine, in Crooked House and Curtain ;; エゼリン（エセリン）『ねじれた家』，『カーテン』 - Takao M.
Eserine, well-known as physostigmine, is classified as an alkaloid. It is a cholinesterase inhibitor and appears in Agatha Christie's novel entitled, Crooked House and Curtain: Poirot's Last Case. In clinical medicine, eserine was used as an ophthalmic tre... (Source: SafetyLit)
Source: SafetyLit - December 16, 2023 Category: International Medicine & Public Health Tags: Poisoning Source Type: news
'I'm an optometrist - red flag signs of diabetes could appear in your eyes'
Around 54 percent of people with diabetes suffer from this symptom, according to an expert. (Source: Daily Express - Health)
Source: Daily Express - Health - December 16, 2023 Category: Consumer Health News Source Type: news
FDA Approves Implant for Glaucoma FDA Approves Implant for Glaucoma
An intracameral implant that releases travoprost into the eye over an extended period to lower intraocular pressure in glaucoma and ocular hypertension will be available commercially in early 2024.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 15, 2023 Category: Drugs & Pharmacology Tags: Ophthalmology Source Type: news
FDA Approves iDose TR (travoprost intracameral implant) for the Treatment of Glaucoma
ALISO VIEJO, Calif.--(BUSINESS WIRE) December 14, 2023 -- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 14, 2023 Category: Drugs & Pharmacology Source Type: news
After Recalls and Infections, Experts Say Safer Eyedrops Will Require New FDA Powers
WASHINGTON — When you buy eyedrops at a U.S. store, you might assume you’re getting a product made in a clean, well-maintained factory that’s passed muster with health regulators.
But repeated recalls involving over-the-counter drops are drawing new attention to just how little U.S. officials know about the conditions at some manufacturing plants on the other side of the world—and the limited tools they have to intervene when there’s a problem.
[time-brightcove not-tgx=”true”]
The Food and Drug Administration is asking Congress for new powers, including the ability to mandat...
Source: TIME: Health - December 13, 2023 Category: Consumer Health News Authors: Matthew Perrone/AP Tags: Uncategorized healthscienceclimate wire Source Type: news
Burden of Visual Impairment Has Increased Globally
TUESDAY, Dec. 12, 2023 -- The number of prevalent cases of visual impairment globally increased substantially in working-age individuals from 1990 to 2019, according to a study published online Dec. 7 in JAMA Ophthalmology.Jianqi Chen, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 12, 2023 Category: Pharmaceuticals Source Type: news
